Geoffrey Omuse1, Daniel Maina2, Mariza Hoffman3, Jane Mwangi4, Caroline Wambua4, Elizabeth Kagotho2, Angela Amayo5, Peter Ojwang6, Zulfiqarali Premji7, Kiyoshi Ichihara8, Rajiv Erasmus3. 1. Department of Pathology, Aga Khan University Hospital Nairobi, P.O. Box 30270-00100, Nairobi, Kenya. g_omuse@yahoo.com. 2. Department of Pathology, Aga Khan University Hospital Nairobi, P.O. Box 30270-00100, Nairobi, Kenya. 3. Division of Chemical Pathology, Department of Pathology, Stellenbosch University, Tygerberg Hospital, P.O. Box 19113, Cape Town, South Africa. 4. PathCare Kenya Ltd, P.O. Box 12560-00606, Nairobi, Kenya. 5. Department of Human Pathology, University of Nairobi, P.O. Box 19676-00200, Nairobi, Kenya. 6. Department of Pathology, Maseno University, P.O. Box Private Bag, Maseno, Kenya. 7. Formerly of Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. 8. Graduate School of Medicine, Faculty of Health Sciences, Yamaguchi University, Minami-Kogushi 1-1-1, Ube, 755-8505, Japan.
The original article [1] was updated to correct a mistake in the third sentence of the conclusions section:‘There is also a need to adopt gender specific MetS TG cut-offs to avoid
diagnosing hypertriglyceridaemia in black African women who have a lower TG level compared to the 1.7 mmol/L cut-off.’Has been changed to:‘There is also a need to adopt gender specific MetS TG cut-offs to avoid
diagnosing hypertriglyceridaemia in black African women who have a lower TG level compared to the 1.7 mmol/L cut-off.’